USA stockpiling of remdesivir: How should the world respond?

被引：2

作者：

Dawoud, Dalia ^{[1
]}

Chalkidou, Kalipso ^{[2
,3
]}

Sullivan, Richard ^{[4
]}

Ruiz, Francis J. ^{[5
]}

Adler, Amanda ^{[6
]}

机构：

[1] Cairo Univ, Fac Pharm, Cairo, Egypt

[2] Ctr Global Dev, London, England

[3] Imperial Coll London, Practice Global Hlth, London, England

[4] Kings Coll London, Canc & Global Hlth, London, England

[5] Imperial Coll London, Ctr Global Dev, London, England

[6] Univ Oxford, NICE Technol Appraisal Comm B, Oxford, England

来源：

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH | 2020年 / 9卷 / 18期

关键词：

antiviral; coronavirus; COVID-19; dexamethasone; remdesivir; SARS-CoV-2; stockpiling;

D O I：

10.2217/cer-2020-0174

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

The race to find an effective treatment for coronavirus disease 2019 (COVID-19) is still on, with only two treatment options currently authorized for emergency use and/or recommended for patients hospitalized with severe respiratory symptoms: low-dose dexamethasone and remdesivir. The USA decision to stockpile the latter has resulted in widespread condemnation and in similar action being taken by some other countries. In this commentary we discuss whether stockpiling remdesivir is justified in light of the currently available evidence.

引用

页码：1243 / 1246

页数：4

共 18 条

[1] [Anonymous], 2020, STAFF WRITER
[2] Remdesivir for the Treatment of Covid-19-Final Report
Beigel, John H.
Tomashek, Kay M.
Dodd, Lori E.
Mehta, Aneesh K.
Zingman, Barry S.
Kalil, Andre C.
Hohmann, Elizabeth
Chu, Helen Y.
Luetkemeyer, Annie
Kline, Susan
de Castilla, Diego Lopez
Finberg, Robert W.
Dierberg, Kerry
Tapson, Victor
Hsieh, Lanny
Patterson, Thomas F.
Paredes, Roger
Sweeney, Daniel A.
Short, William R.
Touloumi, Giota
Lye, David Chien
Ohmagari, Norio
Oh, Myoung-don
Ruiz-Palacios, Guillermo M.
Benfield, Thomas
Faetkenheuer, Gerd
Kortepeter, Mark G.
Atmar, Robert L.
Creech, C. Buddy
Lundgren, Jens
Babiker, Abdel G.
Pett, Sarah
Neaton, James D.
Burgess, Timothy H.
Bonnett, Tyler
Green, Michelle
Makowski, Mat
Osinusi, Anu
Nayak, Seema
Lane, H. Clifford
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (19) : 1813 - 1826
[3] Boseley S., 2020, THE GUARDIAN, DOI [10.1126/science.abe6380, DOI 10.1126/SCIENCE.ABE6380]
[4] Brophy, 2020, US PURCHASES WORLD S
[5] Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
Eastman, Richard T.
Roth, Jacob S.
Brimacombe, Kyle R.
Simeonov, Anton
Shen, Min
Patnaik, Samarjit
Hall, Matthew D.
[J]. ACS CENTRAL SCIENCE, 2020, 6 (05) : 672 - 683
[6] Gilead Sciences, 2020, CO STAT GIL SCI STAT
[7] Dexamethasone in Hospitalized Patients with Covid-19
Horby, Peter
Lim, Wei Shen
Emberson, Jonathan R.
Mafham, Marion
Bell, Jennifer L.
Linsell, Louise
Staplin, Natalie
Brightling, Christopher
Ustianowski, Andrew
Elmahi, Einas
Prudon, Benjamin
Green, Christopher
Felton, Timothy
Chadwick, David
Rege, Kanchan
Fegan, Christopher
Chappell, Lucy C.
Faust, Saul N.
Jaki, Thomas
Jeffery, Katie
Montgomery, Alan
Rowan, Kathryn
Juszczak, Edmund
Baillie, J. Kenneth
Haynes, Richard
Landray, Martin J.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (08) : 693 - 704
[8] John Hopskins University of Medicine, 2020, COVID 19 DASHB CTR S
[9] Leegwater E, 2020, CLIN INFECT DIS, DOI 10.1093/cid/ciaa88
[10] Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review
Nussbaumer-Streit, Barbara
Mayr, Verena
Dobrescu, Andreea Iulia
Chapman, Andrea
Persad, Emma
Klerings, Irma
Wagner, Gernot
Siebert, Uwe
Christof, Claudia
Zachariah, Casey
Gartlehner, Gerald
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (04):

← 1 2 →